Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - TOTAL ASSETS
Total Assets ESPR - Esperion Therapeutics, Inc.
206 M
LAST VALUE
-26.56%
2 YEAR CAGR
7.48%
5 YEAR CAGR
10.15%
10 YEAR CAGR